NeuroServo
Company

Last deal

$1.6M
Local Amount - CAD 2.2M

Amount

Seed

Stage

20.06.2023

Date

6

all rounds

$2.4M

Total amount

General

About Company
NeuroServo has developed a miniaturized prefrontal EEG device designed for emergency situations in Intensive Care Units.

Industry

Sector :

Subsector :

Keywords :

founded date

2015

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

The medical-grade prefrontal EEG device is wireless with single-use dry electrodes, and has been designed to be used as an emergency EEG for ICU/ER, as a screening device (post-operative delirium), and as a CFM (cerebral brain monitor), enabling patients to detect their level of attention in real-time. NeuroServo's algorithms allow for the early detection of cerebral pathologies such as delirium, making it an innovative solution for real-time brainwave analysis and pathology detection.
Contacts